Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has provided an announcement.
EBR Systems, Inc. has received final approval from the U.S. Centers for Medicare & Medicaid Services (CMS) for the New Technology Add-On Payment (NTAP) for its WiSE CRT System, marking a significant milestone in the company’s commercialization strategy. This approval, effective from October 2025, provides a reimbursement pathway for Medicare inpatients and is expected to enhance the commercial appeal of the WiSE System, accelerate its adoption by hospitals, and expand patient access to this innovative cardiac pacing technology across the U.S.
The most recent analyst rating on (AU:EBR) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.
More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
Silicon Valley-based EBR Systems, Inc. is a pioneering company in the medical device industry, focusing on the treatment of cardiac rhythm diseases. They have developed the world’s only wireless cardiac pacing device, known as the WiSE technology, which aims to improve the physiological effectiveness of cardiac resynchronization therapy by eliminating the need for traditional pacing leads. This technology is designed to stimulate the heart’s left ventricle in heart failure patients and has potential applications in treating bradycardia and other non-cardiac conditions.
Average Trading Volume: 908,798
Technical Sentiment Signal: Buy
See more data about EBR stock on TipRanks’ Stock Analysis page.